Ameloblastoma

From WikiMD's Medical Encyclopedia

Revision as of 22:39, 23 March 2025 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A rare, benign tumor of the jaw


Ameloblastoma
Synonyms Adamantinoma of the jaw
Pronounce /əˌmiːloʊbləˈstoʊmə/
Field Oral and maxillofacial surgery, Otorhinolaryngology, Oncology
Symptoms Painless swelling of the jaw, facial deformity, loosening of teeth
Complications Bone destruction, recurrence, rare malignant transformation
Onset Typically in adulthood (30–60 years)
Duration Chronic, slow-growing
Types Multicystic (solid), unicystic, peripheral, desmoplastic
Causes Neoplastic proliferation of odontogenic epithelium; may involve mutations in the BRAF gene
Risks No clear environmental risk factors; possibly genetic predisposition
Diagnosis Radiograph (e.g., panoramic X-ray), CT scan, MRI, biopsy
Differential diagnosis Odontogenic keratocyst, dentigerous cyst, fibrous dysplasia, osteosarcoma
Prevention None known
Treatment Surgical resection with wide margins; enucleation with curettage in some unicystic cases
Medication Targeted therapies (e.g., BRAF inhibitors) under research for recurrent/metastatic cases
Prognosis Good with complete surgical removal; high recurrence with inadequate resection
Frequency Rare; ~1% of all jaw tumors
Deaths Rare; malignant ameloblastoma may metastasize and be fatal


Ameloblastoma
Ameloblastoma
A CT scan of a patient with an ameloblastoma.
The resected left half of a mandible containing an ameloblastoma, initiated at the third molar
Tracheal intubation is difficult in this child with a large ameloblastoma.

Ameloblastoma is a rare, benign tumor that originates in the jawbone or sometimes in the soft tissues of the mouth. It is known for its aggressive local behavior and potential to cause significant bone destruction and facial deformity. Despite being benign, ameloblastomas can recur after treatment and rarely metastasize.

Epidemiology[edit]

Ameloblastomas account for about 1% of all oral tumors and approximately 11% of all odontogenic tumors. They are most commonly diagnosed in adults between the ages of 30 and 60, with no significant gender predilection. The majority of ameloblastomas occur in the mandible, particularly in the molar and ramus regions.

Pathophysiology[edit]

Ameloblastomas arise from the remnants of the dental lamina, the epithelial lining of odontogenic cysts, or from the basal cells of the oral mucosa. The tumor is characterized by the proliferation of ameloblast-like cells, which are similar to the cells that form the enamel of teeth. These cells form nests or islands within a fibrous stroma, leading to the characteristic histological appearance.

Clinical Presentation[edit]

Patients with ameloblastoma typically present with a painless swelling in the jaw, which may be noticed incidentally or due to facial asymmetry. As the tumor grows, it can cause tooth displacement, malocclusion, and paresthesia if it impinges on the inferior alveolar nerve. In advanced cases, the tumor can cause significant bone resorption and pathological fractures.

Diagnosis[edit]

The diagnosis of ameloblastoma is primarily based on imaging studies and histopathological examination. Panoramic radiographs and CT scans are commonly used to assess the extent of the tumor and its effects on the surrounding bone. The radiographic appearance is often described as a "soap bubble" or "honeycomb" pattern due to the multilocular radiolucencies. A definitive diagnosis is made through a biopsy and microscopic examination, which reveals the characteristic ameloblast-like cells.

Treatment[edit]

The treatment of ameloblastoma typically involves surgical resection. The extent of surgery depends on the size and location of the tumor. Options include enucleation, curettage, or more extensive resection with margins to prevent recurrence. In some cases, reconstructive surgery may be necessary to restore function and aesthetics. Radiotherapy and chemotherapy are generally not effective for ameloblastomas.

Prognosis[edit]

The prognosis for patients with ameloblastoma is generally good, with a high survival rate. However, the risk of recurrence is significant, particularly if the tumor is not completely excised. Long-term follow-up is essential to monitor for recurrence. Rarely, ameloblastomas can undergo malignant transformation into ameloblastic carcinoma, which has a poorer prognosis.

Related pages[edit]

External links[edit]



This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.